1381P - Current or former smokers: Who wants to be screened?
Date | 09 October 2016 |
Event | ESMO 2016 Congress |
Session | Poster display |
Topics | Bioethics, Legal, and Economic Issues |
Presenter | Sébastien Couraud |
Citation | Annals of Oncology (2016) 27 (6): 474-482. 10.1093/annonc/mdw387 |
Authors |
S. Couraud1, L. Greillier2, X. Pivot3, L. Guibaudet4, J. Blay5, C. Lhomel6, J. Viguier7, J. Morère8, F. Eisinger9, A.B. Cortot10
|
Abstract
Background
Lung cancer screening (LCS) with annual low-dose CT scans reduced specific and overall mortality in a selected population (age 55-74 yrs, current or former [quit 30 pack-years]). Participation is key to successful screening programs. We assessed smokers' intention to take part in a hypothetical LCS program for smokers.
Methods
The EDIFICE French nationwide observational surveys assess behavior related to cancer screening programs. EDIFICE 4 was conducted from June 12 to July 10 2014 by phone interviews of a representative sample of 1602 subjects (age 40-75 yrs) using the quota method. To identify explanatory factors associated with the intention to take part in a LCS program, we performed 2 comprehensive multivariate stepwise logistic regression analyses: (i) in current and (ii) in former cigarette smokers (who quit
Results
Among those with no personal history of cancer (N = 1463), 263 current and 170 former cigarette smokers were analyzed in the 2 regression models; 36.4% and 26.3% respectively, intended taking part in a LCS program. In current cigarette smokers, the following were explanatory factors of the intention to take part: have been already screened for lung cancer (OR = 2.81; 95% CI [1.37-5.91]; P
Conclusions
Intending to take part in LCS programs is a complex decision. Explanatory factors differ between current and former smokers but usual eligibility criteria are not significantly explanatory. Among current smokers, intended participation is strongly associated with the intention to quit smoking.
Clinical trial identification
Legal entity responsible for the study
The EDIFICE surveys are funded by Roche
Funding
The EDIFICE surveys are funded by Roche
Disclosure
S. Couraud, L. Greillier, X. Pivot, J.-Y. Blay, J-F. Morère, F. Eisinger, A. B. Cortot: Honorarium fees from Roche. C. Lhomel: Employee of Roche. All other authors have declared no conflicts of interest.